Category Archives: Healthcare

A Director at Kindred Biosciences is Exercising Options

Yesterday it was reported that a Director at Kindred Biosciences (KIN – Research Report), Denise Bevers, exercised options to sell 515 KIN shares at $0.32 a share, for a total transaction value of $2,575. See today’s analyst top recommended stocks

Thursday’s Midday Movers: Exact Sciences (EXAS), Rite Aid (RAD), Organovo Holdings (ONVO), Tesla (TSLA), Kinross Gold (KGC)

So far Thursday, September 24, NASDAQ is up 9.52% and the S&P is up 5.26%. Here are this morning’s most active stocks: Exact Sciences (EXAS – Research Report), Rite Aid (RAD – Research Report), Organovo Holdings (ONVO – Research Report),

Constellation Pharmaceuticals (CNST) Receives a Hold from Oppenheimer

In a report released today, Jay Olson from Oppenheimer assigned a Hold rating to Constellation Pharmaceuticals (CNST – Research Report), with a price target of $20.00. The company’s shares closed last Thursday at $17.99. According to TipRanks.com, Olson is ranked

William Blair Initiates a Buy Rating on 9 Meters Biopharma (NMTR)

9 Meters Biopharma (NMTR – Research Report) received a Buy rating from William Blair analyst Tim Lugo on September 22. The company’s shares closed last Thursday at $0.70. According to TipRanks.com, Lugo is a 5-star analyst with an average return

H.C. Wainwright Maintains Their Buy Rating on Pulmatrix (PULM)

In a report released yesterday, Andrew Fein from H.C. Wainwright maintained a Buy rating on Pulmatrix (PULM – Research Report), with a price target of $10.00. The company’s shares closed last Wednesday at $1.19. According to TipRanks.com, Fein is a

H.C. Wainwright Thinks AC Immune SA’s Stock is Going to Recover

In a report released today, Andrew Fein from H.C. Wainwright reiterated a Buy rating on AC Immune SA (ACIU – Research Report), with a price target of $11.00. The company’s shares closed last Wednesday at $4.80, close to its 52-week